Targeting nitric oxide with drug therapy.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 8, Issue 12 Suppl 4, 2006, Pages 40-52

  Mason, R Preston ^a   Cockcroft, John R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BENZOPYRAN DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAZOLE DERIVATIVE; CARVEDILOL; ETHANOLAMINE DERIVATIVE; ISOSORBIDE DINITRATE; NEBIVOLOL; NICORANDIL; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROPANOLAMINE DERIVATIVE; VASODILATOR AGENT;

BIOAVAILABILITY; DEGENERATIVE DISEASE; DRUG ANTAGONISM; HEART DISEASE; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CARBAZOLES; ETHANOLAMINES; HEART DISEASES; HUMANS; ISOSORBIDE DINITRATE; NEURODEGENERATIVE DISEASES; NICORANDIL; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; PROPANOLAMINES; RECEPTORS, ANGIOTENSIN; VASODILATOR AGENTS;

EID: 39049182122     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2006.06041.x     Document Type: Review

References (147)